| abstract |
The present invention is, diseases in which integrin receptor mediated, especially α v β 3, α v β 5, α v effective in the prevention and treatment of diseases, such as diseases or conditions mediated by integrin receptors, such as beta 6 New Including compounds. The present invention includes novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for preventing and treating such diseases and disorders. The present invention also relates to methods for making such compounds, as well as intermediates useful in such methods. |